MCAG

Mountain Crest Acquisition Corp. V · NASDAQ

Sector Finance
Industry Financial Conglomerates
Website mcacquisition.com/Mountain-Crest-V-/default.aspx
Employees(FY) -
ISIN US62404B1070

Performance

-3.28%

-1.98%

+0.83%

+2.59%

+2.16%

YTD

+2.35%

Profile

Mountain Crest Acquisition Corp. V does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to pursue target business opportunities in North America and the Asia Pacific region. Mountain Crest Acquisition Corp. V was incorporated in 2021 and is based in New York, New York. Mountain Crest Acquisition Corp. V operates as a subsidiary of Mountain Crest Global Holdings LLC.

Advanced Technical Analysis

Technical Analysis of MCAG 2024-11-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 3 and the Technical Score at 21, both indicating weak performance. The Oscillators Score of 40 suggests a neutral stance, but overall, the combined scores point to a lack of bullish momentum in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MCAG

Stock Rank

Recent News & Updates

2024-09-18 04:30
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance(Globenewswire)
2024-08-29 06:00
CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed(Globenewswire)
2024-07-24 05:00
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q(Globenewswire)
2024-05-01 21:00
CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V(Globenewswire)
2023-10-24 21:00
Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market(Globenewswire)
2023-05-29 20:00
AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.